Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Metrics In Balance NV's annualized net income for the quarter that ended in Dec. 2024 was €0.01 Mil. Metrics In Balance NV's average shareholder tangible equity for the quarter that ended in Dec. 2024 was €11.70 Mil. Therefore, Metrics In Balance NV's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2024 was 0.08%.
The historical rank and industry rank for Metrics In Balance NV's Return-on-Tangible-Equity or its related term are showing as below:
XPAR:MLMIB'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -1.89 Med: -0.21 Max: 0.08
Current: 0.08
During the past 8 years, Metrics In Balance NV's highest Return-on-Tangible-Equity was 0.08%. The lowest was -1.89%. And the median was -0.21%.
XPAR:MLMIB's Return-on-Tangible-Equity is not ranked
in the Medical Distribution industry.
Industry Median: 8.81
vs XPAR:MLMIB: 0.08
Metrics In Balance NV (XPAR:MLMIB) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Metrics In Balance NV Return-on-Tangible-Equity Related Terms
Metrics In Balance NV Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Metrics In Balance NV's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Metrics In Balance NV Return-on-Tangible-Equity Chart
XPAR:MLMIB vs MCK, COR, CAH: Return-on-Tangible-Equity Comparison
For the Medical Distribution subindustry, Metrics In Balance NV's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Metrics In Balance NV Return-on-Tangible-Equity vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Metrics In Balance NV's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Metrics In Balance NV's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is one times the annual (Dec. 2024) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 0.08% mean?
Metrics In Balance NV (XPAR:MLMIB) has a Return-on-Tangible-Equity of 0.08% as of Dec. 2024. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Metrics In Balance NV and its competitors.
Is Metrics In Balance NV's Return-on-Tangible-Equity too high?
Metrics In Balance NV's current Return-on-Tangible-Equity is 0.08%. The Medical Distribution industry median Return-on-Tangible-Equity is 8.81. Metrics In Balance NV's value of 0.08% is 99.1% below this industry median. Overall, Metrics In Balance NV has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Metrics In Balance NV's Return-on-Tangible-Equity compare to MCK and COR?
Metrics In Balance NV's Return-on-Tangible-Equity of 0.08% can be compared against companies in the Medical Distribution industry. The industry median Return-on-Tangible-Equity is 8.81. Metrics In Balance NV's value of 0.08% is 99.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Distribution company?
The median Return-on-Tangible-Equity among Medical Distribution companies is 8.81, based on 111 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Metrics In Balance NV's current Return-on-Tangible-Equity of 0.08% is 99.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Metrics In Balance NV and its competitors. For the Medical Distribution industry, the median Return-on-Tangible-Equity is 8.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Metrics In Balance NV's current Return-on-Tangible-Equity is 0.08%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Metrics In Balance NV stock overvalued right now?
Metrics In Balance NV (XPAR:MLMIB) has a current Return-on-Tangible-Equity of 0.08%. The current Return-on-Tangible-Equity is 0.08% and 99.1% below the Medical Distribution industry median of 8.81. Metrics In Balance NV's overall GF Score™ is 4/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Metrics In Balance NV (XPAR:MLMIB), the current Return-on-Tangible-Equity is 0.08% as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Metrics In Balance NV is engaged in the sale of medical devices for the measurement, diagnosis, and resolution of disorders related to dental occlusion malfunction.
4GF Score
Get the complete analysis for XPAR:MLMIB
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:MLMIB has been successfully added to your 
